Rebetol and Oxygen saturation decreased - a phase IV clinical study of FDA data

Summary:

Oxygen saturation decreased is found among people who take Rebetol, especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Rebetol and have Oxygen saturation decreased. It is created by eHealthMe based on reports of 25,849 people who have side effects when taking Rebetol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 13, 2022

25,849 people reported to have side effects when taking Rebetol.
Among them, 25 people (0.1%) have Oxygen saturation decreased.


What is Rebetol?

Rebetol has active ingredients of ribavirin. eHealthMe is studying from 25,874 Rebetol users for its effectiveness, alternative drugs and more.

What is Oxygen saturation decreased?

Oxygen saturation decreased is found to be associated with 2,370 drugs and 1,932 conditions by eHealthMe.

Number of Rebetol and Oxygen saturation decreased reports submitted per year:

Could Rebetol cause Oxygen saturation decreased?

Time on Rebetol when people have Oxygen saturation decreased *:

  • < 1 month: 40 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 10 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Oxygen saturation decreased when taking Rebetol *:

  • female: 52.17 %
  • male: 47.83 %

Age of people who have Oxygen saturation decreased when taking Rebetol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 4.55 %
  • 20-29: 4.55 %
  • 30-39: 18.18 %
  • 40-49: 27.27 %
  • 50-59: 31.82 %
  • 60+: 13.64 %

Common drugs people take besides Rebetol *:

  1. Peg-Intron: 13 people, 52.00%
  2. Intron A: 4 people, 16.00%
  3. Acyclovir: 3 people, 12.00%
  4. Omeprazole: 3 people, 12.00%
  5. Zoloft: 3 people, 12.00%
  6. Tylenol: 2 people, 8.00%
  7. Prograf: 2 people, 8.00%
  8. Ganciclovir: 2 people, 8.00%
  9. Cytarabine: 2 people, 8.00%
  10. Mylotarg: 2 people, 8.00%

Common side effects people have besides Oxygen saturation decreased *:

  1. Breathing Difficulty: 9 people, 36.00%
  2. Fever: 7 people, 28.00%
  3. Nausea (feeling of having an urge to vomit): 6 people, 24.00%
  4. Dehydration (dryness resulting from the removal of water): 6 people, 24.00%
  5. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 5 people, 20.00%
  6. Cough: 5 people, 20.00%
  7. Pain: 5 people, 20.00%
  8. Dizziness: 5 people, 20.00%
  9. Rashes (redness): 5 people, 20.00%
  10. Depression: 5 people, 20.00%

Common conditions people have *:

  1. Hepatitis C: 16 people, 64.00%
  2. Acute Leukaemia (blood cancer): 2 people, 8.00%
  3. Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 8.00%
  4. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 8.00%
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 4.00%
  6. Adenovirus Infection: 1 person, 4.00%
  7. Anaemia (lack of blood): 1 person, 4.00%
  8. Blood Uric Acid Decreased: 1 person, 4.00%
  9. Cancer Pain: 1 person, 4.00%
  10. Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Rebetol and have Oxygen saturation decreased?

Check whether Oxygen saturation decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of Rebetol:

Oxygen saturation decreased treatments and more:

COVID vaccines that are related to Oxygen saturation decreased:

How severe was Oxygen saturation decreased and when was it recovered:

Expand to all the drugs that have ingredients of ribavirin:

Common drugs associated with Oxygen saturation decreased:

All the drugs that are associated with Oxygen saturation decreased:

Common conditions associated with Oxygen saturation decreased:

All the conditions that are associated with Oxygen saturation decreased:

How the study uses the data?

The study uses data from the FDA. It is based on ribavirin (the active ingredients of Rebetol) and Rebetol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: